Skip to main content

Table 3 Total burden scores by socio-demographic and clinical variables

From: The relationship between self-efficacy and treatment satisfaction among patients with anticoagulant therapy: a cross-sectional study from a developing country

Variable Frequency % N(300) Median (Q1–Q3) Mean ± SD Mean
rank
P-value
Age category (years) 0.651 b
  < 30 31 (10.3) 42.00(34.00–52.00) 41.68 ± 11.02 141.21
 30–60  163 (54.3) 43.00(37.00–51.00) 43.99 ± 10.77 154.47
  > 60 106 (35.3) 45.00(36.00–50.00) 42.73 ± 91.78 147.11
Gender 0.006 a
 Male  115 (38.3) 46.00(38.00–52.00) 45.01 ± 9.88 168.03
 Female  185 (61.7) 42.00(35.00–49.00) 42.25 ± 10.68 139.60
BMIa 0.702 b
 Normal  65 (21.7) 42.00(35.00–50.00) 42.89 ± 9.89 140.45  
 Overweight  136 (45.3) 44.00(36.25–51.75) 43.44 ± 10.15 151.19  
 Obese  93 (31.0) 44.00(37.00–50.50) 43.55 ± 11.48 147.04  
Education 0.160 b
 Illiterate 20 (6.7) 39.00(29.25–49.50) 39.60 ± 11.17 118.63
 Elementary 43 (14.3) 46.00(36.75–50.25) 43.31 ± 9.19 149.86
 Primary 52 (17.3) 42.00(35.00–49.00) 41.06 ± 10.13 131.38
 Secondary 54 (18.0) 45.00(38.75–54.00) 45.67 ± 9.60 165.19
 University 124 (41.3) 43.00(36.00–50.75) 43.80 ± 11.25 146.76
Income (month) 0.001b
 Less than 2000 NIS 23 (7.7) 40.00(31.00–46.00) 38.60 ± 8.74 108.11  
 2000–5000 NIS 160(53.3) 42.00(35.00–50.00) 41.93 ± 9.44 136.66
 More than 5000 NIS 108(36.0) 45.00(40.00–53.00) 46.06 ± 11.10 167.91
locality 0.123 b
 Camp 36(12.0) 41.00(35.00–48.50) 41.47 ± 8.55 131.01
 Rural 85(28.3) 40.00(34.00–50.00) 41.83 ± 11.09 136.84
 Urban 172(57.3) 44.00(37.25–51.00) 49.17 ± 10.13 155.37
Marital status 0.005a
 Married 229(76.3) 44.00(37.00–51.00) 44.29 ± 10.26  
 Unmarried (single, divorced, widowed) 67(22.3) 41.00(31.00–49.00) 39.86 ± 10.32
Employment status 0.114 a
 Employed 194(64.7) 42.00(35.75–50.25) 44.76 ± 11.55 158.40
 Unemployed 100(33.3) 45.00(36.25–52.00) 42.61 ± 9.88 141.88
Chronic co-morbid disease 0.696 b
 No co-morbid disease 42 (14.0) 44.00(38.00–52.00) 44.24 ± 8.25 156.31
 One disease 44(14.7) 45.00(35.00–53.00) 44.67 ± 11.45 156.79
 Two diseases 63(21.0) 42.00(36.00–51.00) 42.35 ± 9.26 141.24
 Three diseases or more 146(48.7) 44.00(36.00–50.00) 43.41 ± 11.05 144.93
Indications for anticoagulant 0.366 b
 Atrial fibrillation 63 (21.0) 43.00 (37.00–50.00) 42.54 ± 8.60 145.65
 Deep vein thrombosis or Pulmonary embolism 29 (9.7) 41.00 (34.00–46.50) 41.00 ± 8.41 126.03
 Prophylaxis c 72 (24.0) 44.00 (37.00–52.00) 43.57 ± 10.16 154.79
 Other indications 136 (45.3) 45.00 (36.00–51.00) 44.01 ± 11.71 155.69
Chronic medications 0.932 a
≤4 176(58.7) 43.00(36.00–51.00) 43.43 ± 11.05 150.86
  > 4 124(41.3) 43.00 (36.00–50.00) 43.14 ± 9.57 149.99
Anticoagulant drug
 UHF 87(29) 42.00(35.00–51.00) 42.75 ± 9.63 143.83 0.596 b
 Vit-K dependent 134(44.7) 43.00 (36.00–51.00) 41.65 ± 11.06 143.90
 NOACs 75(25) 44.00 (36.75–57.00) 44.12 ± 11.43 154.06
  1. a The statistical significance of differences was calculated using the Mann-Whitney U test
  2. b The statistical significance of the differences was calculated using the Kruskal-Wallis test
  3. Bold P-value indicates a significant difference
  4. cPatients that received prophylactic doses of unfractionated heparin during hospital admission
  5. NIS: New Israeli Shekel (0.29 US Dollar)